TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754,766 | -1.9% | 41,769 | -31.7% | 0.00% | – |
| Q1 2023 | $769,008 | -7.5% | 61,178 | +7.8% | 0.00% | – |
| Q4 2022 | $831,721 | +19.5% | 56,734 | +39.5% | 0.00% | – |
| Q3 2022 | $696,000 | +11.9% | 40,663 | -4.6% | 0.00% | – |
| Q2 2022 | $622,000 | +32.1% | 42,617 | +52.3% | 0.00% | – |
| Q1 2022 | $471,000 | -12.5% | 27,982 | +17.1% | 0.00% | – |
| Q4 2021 | $538,000 | -12.7% | 23,904 | -16.5% | 0.00% | – |
| Q3 2021 | $616,000 | -30.2% | 28,614 | -6.0% | 0.00% | – |
| Q2 2021 | $882,000 | -6.5% | 30,428 | +4.0% | 0.00% | – |
| Q1 2021 | $943,000 | +17.7% | 29,259 | +51.1% | 0.00% | – |
| Q4 2020 | $801,000 | – | 19,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |